A new life-changing treatment option – GLP-1 drug semaglutide known as Wegovy – is set to be available on the NHS within months, with 1.2 million people with cardiovascular disease eligible to receive the treatment to help prevent heart attacks and strokes over the next few years. People with heart and circulatory disease who are […]
SBRI Healthcare has awarded a total of £1 million to ten pioneering MedTech and Digital innovations to support the delivery of a Net Zero NHS. The new projects are funded through a nationwide call by SBRI Healthcare, in partnership with the Greener NHS Programme, and which attracted 46 applications from a range of organisations, including […]
NHS England has today (Thursday 23 May, 2013) confirmed the designation of 15 new Academic Health Science Networks (AHSNs). AHSNs have the potential to transform health and healthcare by putting innovation at the heart of the NHS. This will improve patient outcomes as well as contributing to economic growth. AHSNs present a unique opportunity to […]